Rabies Vaccine Market: Current Analysis and Forecast (2022-2030)

The rabies vaccine is a vaccine used to prevent rabies, a viral disease that affects the nervous system and is transmitted through the saliva of infected animals. The vaccine is designed to stimulate the immune system to produce antibodies against the rabies virus, providing protection against the disease. The global rabies vaccine market has been experiencing steady growth due to increasing awareness about the prevention of rabies, particularly in regions where the disease is endemic. For instance, as per the World Health Organization (WHO), It is estimated that 59,000 people die from rabies in more than 150 countries each year, 95% of which occur in Africa and Asia.

Rabies Vaccine Market is expected to grow at a strong CAGR of 5% during the forecast period owing to the increasing adoption of animals. For instance, as per the World Animal Foundation, in 2022, About 90.5 million livestock live in 70% of households with pets.

Based on product type, the market is segmented into vero cell rabies vaccine, baby hamster kidney (BHK), chick embryo cell rabies vaccine, and others. As per our analysis, the vero cell rabies vaccine segment acquired a major share in 2021. Vero cell rabies vaccine is an inactivated rabies vaccine that is produced using Vero cells, which are a continuous line of monkey kidney cells. This type of vaccine has been widely used for several years for rabies immunization. It has been found to be safe and effective in preventing rabies in humans. The for effective rabies prevention, particularly in regions where rabies is prevalent. Rabies is a viral disease that affects the central nervous system and is almost always fatal once symptoms appear are the main reasons for the growth of the segment.

Based on the application, the market is segmented into pre-exposure prophylaxis and post-exposure prophylaxis. The pre-exposure prophylaxis segment is expected to grow with a higher CAGR in the rabies vaccine market during the forecast period. The increasing awareness about the rabies and increasing pet population attributes to the fast growth of the segment during the forecast period.

Based on the distribution channel, the market is segmented into hospital pharmacy, online pharmacy, and retail pharmacy. As per our analysis, the hospital pharmacy segment acquired a major share in 2021. Hospital pharmacies play a crucial role in the rabies vaccine market by ensuring the availability, storage, and distribution of rabies vaccines to healthcare facilities and patients. Hospital pharmacies are responsible for procuring an adequate supply of rabies vaccines from vaccine manufacturers or authorized distributors. They monitor vaccine inventory levels, expiration dates, and ensure proper storage conditions to maintain vaccine efficacy.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North American region held the dominant share of the Rabies Vaccine market in 2021. Governments in North America have implemented vaccination programs and regulations to control rabies. These initiatives promote the use of rabies vaccines for both domestic animals and wildlife. Further, there is generally a high level of awareness about rabies and its prevention measures among the general public in North America. This awareness drives the demand for rabies vaccines, as individuals are more likely to seek vaccination for themselves and their pets.

Some of the major players operating in the market include: Serum Institute of India Pvt. Ltd.; Novartis AG; Cadila Pharmaceuticals; Merck & Co., Inc.; Sanofi; Berna Biotech Pharma GmbH.; AstraZeneca.; Boehringer Ingelheim International GmbH; Elanco; and Zoetis.